A high level of TLR9 expression in prostate cancer cells was shown to be significantly associated with a higher Gleason score, a greater probability of biochemical recurrence and poor progression-free survival in patients who were treated by radical prostatectomy [13]. Here, TLR9 is linked to prostate cancer.